Cancer BiologyPediatric Blood & CancerPeer-reviewed
Determining preclinical safety of Aclarubicin in pediatric malignancies
Darleen S. Tu, Aaron K Olson, Kimberly S. Waggie…·Shireen S. Ganapathi
This study evaluates Aclarubicin's safety and efficacy in pediatric cancer models, finding it effective with reduced genotoxicity and cardiotoxicity compared to doxorubicin.
DOI 10.1002/pbc.32169